Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study

• Published in: Diabetic medicine 2012-09, Vol.29 (9), p.e326-e333
• Main Authors: Ali, M., Schifano, F., Robinson, P., Phillips, G., Doherty, L., Melnick, P., Laming, L., Sinclair, A., Dhillon, S.
• Format: Article
• Language: English
• Subjects: Aged; Blood Pressure - physiology; Body Mass Index; community pharmacy; Community Pharmacy Services; diabetes education; Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - physiopathology; Diabetes Mellitus, Type 2 - therapy; diabetes monitoring; Disease Management; Female; Glycated Hemoglobin A - metabolism; Humans; Lipids - blood; Longitudinal Studies; Male; Middle Aged; Patient Education as Topic; pharmaceutical care; Pilot Projects; Prospective Studies; State Medicine; United Kingdom
• ISSN: 0742-3071; 1464-5491
• DOI: 10.1111/j.1464-5491.2012.03725.x

Diabet. Med. 29, e326–e333 (2012) Aims  To evaluate the impact of a pharmacist‐led patient education and diabetes monitoring programme on HbA1c and other cardiovascular risk factors in the community setting. Methods  Patients with Type 2 diabetes (n = 46) attending two community pharmacies in Hertfordshire, UK were randomized to one of two groups. Patients in the intervention group (n = 23) received a programme of education about diabetes, its treatment and associated cardiovascular risk factors. These patients were seen for monitoring/counselling by a community pharmacist on six occasions over a 12‐month period. Measures included HbA1c, BMI, blood pressure, blood glucose and lipid profile. Patients in the control group (n = 23) underwent these measurements at baseline and at 12 months only, without specific counselling or education over and above usual care. Results  HbA1c fell from 66 mmol/mol (8.2%) to 49 mmol/mol (6.6%) (P